Yashica Pharmaceuticals Private Limited

Yashica Pharmaceuticals Private Limited - pharma in Kalyan West, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH2007PTC175913 Incorporated 15 November 2007 ROC Mumbai HQ Kalyan West, Maharashtra, India
Active Private Limited Company pharma MSME
Data last updated
Revenue · FY 2025
₹17.2 Cr
▲ 66% YoY
Net profit · FY 2025
₹1.96 Cr
Net margin 11.4%
EBITDA · FY 2025
₹2.73 Cr
EBITDA margin 15.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹22.97 Cr
Satisfied ₹2 Cr
Company age
19 yrs
Est. 2007
Directors on board
2
As per MCA filings

About Yashica Pharmaceuticals Private Limited

Data last updated:

Yashica Pharmaceuticals Private Limited is a private limited company based in Kalyan West, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 November 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2007PTC175913. Its GSTIN is 27AAACY3217A1ZT (Maharashtra). The company holds 3 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sanjay Khandu Totare and Vaishali Sanjay Totare.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 101 Lalji Arcade B Wing Opp. Saibaba Mandir Santoshi Mata Mandir Road, Kalyan West, Maharashtra, India – 421301.

As per the financials filed for FY 2025, the company reported a revenue of ₹17.2 Cr, a growth of 66% compared to the previous year. For the same year it recorded a net profit of ₹1.96 Cr (net margin 11.4%) and EBITDA of ₹2.73 Cr (EBITDA margin 15.9%). Revenue has grown at a compounded annual rate (CAGR) of 49% over three years.

As per MCA filings, the company has open charges of ₹22.97 Cr and satisfied charges of ₹2 Cr on record.

Yashica Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-33-0032226). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pharmarawmaterials.com.

Company details

CIN U24230MH2007PTC175913
Registration Number 175913
Incorporation Date 15 November 2007
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-33-0032226
Key People
Sanjay Khandu Totare Director Vaishali Sanjay Totare Director

Recognitions & Rankings of Yashica Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Udyam number
UDYAM-MH-33-0032226

Contact details

Yashica Pharmaceuticals Private Limited's registered office is in Kalyan West, Maharashtra. Its website is pharmarawmaterials.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    pharmarawmaterials.com
  • Registered Address
    101 Lalji Arcade B Wing Opp. Saibaba Mandir Santoshi Mata Mandir Road, Kalyan West, Maharashtra, India – 421301
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Yashica Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Yashica Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Yashica Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Yashica Pharmaceuticals Private Limited, buy the company report.

Financials of Yashica Pharmaceuticals Private Limited

FY 2025 filings available

Yashica Pharmaceuticals Private Limited reported revenue of ₹17.2 Cr (up 66% YoY) for FY 2025.

Revenue · FY 2025
₹17.2 Cr ▲ 66%
Net profit · FY 2025
₹1.96 Cr margin 11.4%
EBITDA · FY 2025
₹2.73 Cr margin 15.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 66%
3 years · compounded
▲ 49%
EBITDA CAGR growth
1 year
▲ 178%
3 years · compounded
▲ 70%

Revenue has grown at a compounded annual rate (CAGR) of 49% over three years, including 66% growth in the latest year. EBITDA rose 178% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹17.2 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.73 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.96 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin15.9%
Net Profit Margin11.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Yashica Pharmaceuticals Private Limited, buy the company report.

Board of directors of Yashica Pharmaceuticals Private Limited

Yashica Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sanjay Khandu Totare
Also directs: Perivinc Pharmaceuticals Private Limited
Director15 Nov 200718 Years 11 MonthsCurrent
Vaishali Sanjay Totare
Also directs: Perivinc Pharmaceuticals Private Limited
Director15 Nov 200718 Years 11 MonthsCurrent
View all directors

Auditor

Yashica Pharmaceuticals Private Limited is audited by Madan Achwal & Co for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Madan Achwal & CoFY 2023105693W

Shareholding

The shareholding of Yashica Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Yashica Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹22.97 Cr
Satisfied charges
₹2 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹22.97 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
25 Feb 2026101277671Hdfc Bank Limited₹1.8 CrOpen
25 Nov 2025101201512Hdfc Bank Limited₹21.17 CrOpen
01 Feb 2023100687665Axis Bank Limited₹2 CrSatisfied

To see the full charge records of Yashica Pharmaceuticals Private Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Yashica Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Yashica Pharmaceuticals has 3 GST registrations: 2 active and 1 cancelled or inactive.

Total GSTINs
3
Active
2
Cancelled / inactive
1
GSTINStateStatusRegistered on
27AAACY3217A1ZTMaharashtraActive01 Jul 2017
27AAACY3217A2ZSMaharashtraActive17 Feb 2025

To see the full GST registrations and return filing status of Yashica Pharmaceuticals Private Limited, buy the company report.

Recent activity

Yashica Pharmaceuticals Private Limited has 2 board changes on record since 2007: 2 appointments. The latest: Sanjay Khandu Totare was appointed as Director on 15 Nov 2007.

Charges
A charge with Hdfc Bank Limited of Rs. 2,117.00 Lakh registered on 25 Nov 2025 with Charge ID 101201512 was modified on 15 Jul 2026.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 180.00 Lakh with Charge ID 101277671 was registered on 25 Feb 2026.
Charges
A charge registered on 01 Feb 2023 via Charge ID 100687665 with Axis Bank Limited was fully satisfied on 27 Jan 2026.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2,117.00 Lakh with Charge ID 101201512 was registered on 25 Nov 2025.
AGM
Yashica Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Yashica Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge with Axis Bank Limited amounted to Rs. 200.00 Lakh with Charge ID 100687665 was registered on 01 Feb 2023.
Appointed
Sanjay Khandu Totare was appointed as Director.
Appointed
Vaishali Sanjay Totare was appointed as Director.
Incorporation
15 Nov 2007
Yashica Pharmaceuticals Private Limited was registered on 15 Nov 2007 with Roc Mumbai Ii & aged 18 years 11 months as per MCA records.

Frequently asked questions

Yashica Pharmaceuticals is an active private limited company based in Kalyan West, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 November 2007 (19+ years old) and is registered under CIN U24230MH2007PTC175913.

Yashica Pharmaceuticals has 2 current directors:

The latest financial statements of Yashica Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Yashica Pharmaceuticals is 27AAACY3217A1ZT, registered in Maharashtra. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 27AAACY3217A2ZS (Maharashtra).

The CIN (Corporate Identification Number) of Yashica Pharmaceuticals is U24230MH2007PTC175913. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yashica Pharmaceuticals was incorporated on 15 November 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.

Sanjay Khandu Totare was appointed as Director on 15 Nov 2007. Vaishali Sanjay Totare was appointed as Director on 15 Nov 2007.

Yes, Yashica Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-MH-33-0032226).

Yashica Pharmaceuticals can be reached through the website pharmarawmaterials.com. Its registered office is in Kalyan West, Maharashtra, India.

The registered office of Yashica Pharmaceuticals is at 101 Lalji Arcade B Wing Opp. Saibaba Mandir Santoshi Mata Mandir Road, Kalyan West, Maharashtra, India – 421301.